Blood Stream Infections
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
M&
Merck & Co.RAHWAY, NJ
1 programClinical Outcomes in Candidemia Patients Based on in Vitro SusceptibilityN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
Clinical Trials (1)
Total enrollment: 450 patients across 1 trials
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
Start: Jan 2010Est. completion: Jan 2011450 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space